GNPX
$2.02
Market ClosedAs of Mar 17, 8:00 PM UTC
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.